Bridging the gap between patient and physician perspectives on management of generalized myasthenia gravis: a Delphi consensus study. [PDF]
Chan A +6 more
europepmc +1 more source
Double-Filtration Plasmapheresis Versus Efgartigimod for Generalized Myasthenia Gravis: Severity-Stratified Benefits in a Prospective Observational Multicenter Study. [PDF]
Wang K +16 more
europepmc +1 more source
Appropriate use of steroids for patients with generalized Myasthenia Gravis: an international Delphi study. [PDF]
Wiendl H +5 more
europepmc +1 more source
Generalized Myasthenia Gravis with Spasmodic Dysphonia
Woo-Chan Choi +2 more
openaire +1 more source
Complement Inhibitors in Generalized Myasthenia Gravis: Comparison of Administration Schedules, Efficacy, and Safety. [PDF]
Di Martino G +8 more
europepmc +1 more source
Alterations in plasma cytokine profiles in generalized myasthenia gravis following different immunotherapeutic regimens. [PDF]
Ren Z +6 more
europepmc +1 more source
Burden of glucocorticoid use in commercially insured adults with generalized myasthenia gravis in the United States: A retrospective claims-based analysis. [PDF]
Silvestri NJ +8 more
europepmc +1 more source
Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study. [PDF]
Lin J +10 more
europepmc +1 more source
Usefulness of Early Treatment with Efgartigimod in Patients with Generalized Myasthenia Gravis Complicated by Cardiovascular Disease: A Case Report. [PDF]
Kawakita R, Deguchi K.
europepmc +1 more source
Treatment Preferences of Neurologists in Generalized Myasthenia Gravis: A Conjoint Analysis Study. [PDF]
Querol L +13 more
europepmc +1 more source

